Instituto Atena de Pesquisa Clínica

Natal, Rio Grande do Norte 59020-500

1 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, COVID-19, Cardiovascular Disease, Coronary Revascularization, Myocardial Infarction, Obesity, Overweight, Stroke

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
• A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects — Completed